MIFAM-DTI:一种基于多源信息融合和注意力机制的药物向相互作用预测模型
Jianwei Li1, Lianwei Sun1, Lingbo Liu1
1Institute of Computational Medicine, School of Artificial Intelligence, Hebei University of Technology, Tianjin, China.
Frontiers in genetics
|May 21, 2024
概括
本研究介绍了MIFAM-DTI,这是一种用于预测药物向相互作用的深度学习模型. 它有效地整合了多源数据和注意力机制,在药物发现的准确性和效率方面超过了现有的方法.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 准确的药物向相互作用 (DTI) 预测对于药物开发和重新定位至关重要.
- 当前的机器学习和深度学习模型在提高DTI预测准确性和效率方面面临着挑战.
- 需要先进的计算方法来提高潜在的药物标对的识别.
研究的目的:
- 提出一种新的深度学习方法,即药物向相互作用的多源信息融合和注意力机制 (MIFAM-DTI),用于预测DTI.
- 通过整合多种数据源和先进的注意力机制,提高DTI预测的准确性和效率.
- 为了验证拟议的MIFAM-DTI模型的有效性和实用性.
主要方法:
- 提取了药物的物理化学和分子指纹特征 (来自SMILES) 和双组成以及标的进化特征 (来自氨基酸序列).
- 通过PCA减少特征维度,并通过共弦相似性构建相邻矩阵.
- 使用图表注意力网络 (GAT) 和多头自我注意力机制来学习全面的药物和目标特征表示.
- 连接的最终特征向量用于输入到一个完全连接的层,用于DTI预测.
主要成果:
- 与最先进的方法相比,MIFAM-DTI表现出更高的性能,由更高的AUC和AUPR值证明.
- 该模型有效地整合了多个来源的信息,以全面捕获特征.
- 在GAT和多头自我注意力中注意力机制自主学习重量,增强序列数据分析.
- 一个关于细胞能量代谢中的辅酶的案例研究验证了该模型的实际实用性.
结论:
- MIFAM-DTI提供了一种强大而准确的方法来预测药物向相互作用.
- 多源数据和注意力机制的整合显著提高了预测能力.
- 该模型显示了加速药物发现和开发管道的前景.
相关概念视频
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K


